Hepatitis C virus infection among First Nation and non-First Nation people in Manitoba, Canada - A public health laboratory study

Canadian Journal of Microbiology

Volumn 52, Issue 10, 2006, Pages 999-1005

  Dawood, Magdy ^a,b   Smart, Gerry ^a   Wood, Michelyn ^c   Wu, Hong Xing ^c   Paton, Shirley ^c   Wu, Jun ^c  

^a CADHAM PROVINCIAL LABORATORY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Genotyping; Hepatitis A virus; Hepatitis B virus; Mixed infection; Self limiting infection

Indexed keywords

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; DISEASES; HEALTH CARE; PATIENT MONITORING;

CLINICAL SERUM; DEMOGRAPHIC INFORMATION; GENOTYPING; HEPATITIS C VIRUS; PUBLIC HEALTH LABORATORY; SELF-LIMITING INFECTION;

VIRUSES;

HEPATITIS A ANTIBODY; HEPATITIS C ANTIBODY; VIRUS RNA;

ANTIBODY; ETHNICITY; GENETIC VARIATION; GENOTYPE; HEPATITIS; INDIGENOUS POPULATION; INFECTIOUS DISEASE; VIRUS;

ARTICLE; CANADA; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENETIC DIFFERENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INFECTION RATE; INFECTION SENSITIVITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH;

COHORT STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INDIANS, NORTH AMERICAN; MALE; MANITOBA; PUBLIC HEALTH;

CANADA; MANITOBA; NORTH AMERICA;

HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 33846458231     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W06-056     Document Type: Article

References (20)

1. Alter, M.J., Kruszon-Moran, D., Nainan, O.V., McQuillan, G.M., Gao, F., Moyer, L.A., Kaslow, R.A., and Margolis, H.S. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341(8): 556-562.
2. Blight, K.J., Grakoui, A., Hanson, H.L., and Rice, C.M. 2002. The molecular biology of hepatitis C virus. In Hepatitis virus. Edited by J.-H.J. Ou. Kluwer Academic Publishers, Boston, Mass., USA. pp. 81-108.
3. Cramp, M.E., Carucci, P., Underhill, J., Naoumov, N.V., Williams, R., and Donaldson, P.T. 1998. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J. Hepatol. 29(2): 207-213.
4. Bisceglie, A.M., Lyra, A.C., Schwartz, M., Reddy, R.K., Martin, P., Gores, G., Lok, A.S.F., Hussain, K.B., Gish, R., Van Theil, D.H., Younossi, Z., Tong, M., Hassanein, T., Balart, L., Fleckenstein, J., Flamm, S., Blei, A., Befeler, A.S., et al. 2003. Hepatitis C-related hepatocellular carcinoma in United States: influence of ethnic status. Am. J. Gastroenterol. 98(9): 2060-2063.
5. Fleckenstein, J. 2004. Chronic hepatitis C in African Americans and other minority groups. Curr. Gastroenterol. Rep. 6(1): 66-70.
6. Gerlach, J.T., Diepolder, H.M., Zachoval, R., Gruener, N.H., Jung, M.-C., Ulsenheimer, A., Schraut, W.W., Schirren, C.A., Waechtler, M., Backmund, M., and Pape, G.R. 2003. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology, 125: 80-88.
7. Grüner, N.H., Gerlach, T.J., Jung, M.C., Diepolder, H.M., Schirren, C.A., Schraut, W.W., Hoffmann, R., Zachoval, R., Santantonio, T., Cucchiarini, M., Cerny, A., and Pape, G.R. 2000. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J. Infect. Dis. 181: 1528-1536.
8. Hepburn, M.J., Hepburn, L.M., Cantu, N.S., Lapeer, M.G., and Lawitz, E.J. 2004. Difference in treatment outcome for hepatitis C among ethnic groups. Am. J. Med. 117(3): 163-168.
9. Jeffers, L.J., Cassidy, W., Howell, C.D., Hu, S., and Reddy, R. 2004. Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1. Hepatology, 39(6): 1702-1708.
10. Layden-Almer, J.E., Ribeiro, R.M., Wiley, T., Perelson, A.S., and Layden, T.J. 2003. Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin. Hepatology, 37(6): 1343-1350.
11. Nguyen, M.H., Whittemore, A.S., Garcia, R.T., Tawfeek, S.A., Ning, J., Lam, S., Wright, T.L., and Keeffe, E.B. 2004. Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Clin. Gastroenterol. Hepatol. 2(9): 820-824.
12. Orland, J.R., Wright, T.L., and Cooper, S. 2001. Acute hepatitis C. Hepatology, 33: 321-327.
13. Reddy, K.R., Hoofnagle, J.H., Tong, M.J., Lee, W.M., Pockros, P., Heathcote, E.J., Albert, D., and Joh, T. 1999. Racial differences in response to therapy with interferon in chronic hepatitis C. Hepatology, 30: 787-793.
14. Rosen, H.R., Miner, C., Sasaki, A.W., Lewinsohn, D.M., Conrad, A.J., Bakke, A., Bouwer, H.G., and Hinrichs, D.J. 2002. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology, 35: 190-198.
15. Shoukry, N.H., Cowthon, A.G., and Walker, C.M. 2004. Cell-mediated immunity and the outcome of hepatitis C virus infection. Ann. Rev. Microbiol. 58: 391-424.
16. Theodore, D., Shiffman, M.L., Sterling, R.K., Bruno, C.J., Weinstein, J., Crippin, J.S. Garcia, G., Wright, T.L., Conjeevaram, H., Reddy. R.K., Nolte, F.S., and Fried, M.W. 2003. Intensive interferon therapy does not increase virological response rates in African Americans with chronic hepatitis C. Dig. Dis. Sci. 48(1): 140-145.
17. Thursz, M., Yallop, R., Goldin, R., Trepo, C., and Thomas, H.C. 1999. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet, 354(9196): 2119-2124.
18. Villano, S.A., Vlahov, D., Nelson, K.E., Cohn, S., and Thomas, D.L. 1999. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology, 29: 908-914.
19. Wiley, T.E., Brown, J., and Chan, J. 2002. Hepatitis C infection in African Americans: its natural history and histological progression. Am. J. Gastroenterol. 97(3): 700-706.
20. Yee, L.J. 2004. Host genetic determinants in hepatitis C virus infection. Genes Immun. 5(4): 237-245.